Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 17,921–17,940 of 17,987 drug recalls

Drug Recall Terminated Historical recordClass II

Dr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-127-05

by Dr. Reddy's Laboratories, Inc.

Reason
Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets
Recall initiated
April 9, 2012
Reported by FDA
August 8, 2012
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg, 500 Capsules, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-340-05

by Dr. Reddy's Laboratories, Inc.

Reason
Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets.
Recall initiated
April 9, 2012
Reported by FDA
August 8, 2012
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Estradiol Hemihydrate M20 EP/USP Powder, packaged in a) 1.5 kg and b) 2.5 kg fiber drums, Rx only, Art. No. 165811, Bayer Pharma AG, D-13342 Berlin.

by Bayer Healthcare Pharmaceuticals Inc.

Reason
Cross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product.
Recall initiated
May 8, 2012
Reported by FDA
August 8, 2012
Distribution
Kansas and California.

View recall →

Drug Recall Terminated Historical recordClass II

OFIRMEV (acetaminophen) injection, 1000 mg/100 mL (10 mg/mL), 24-count Single Use 100 mL Vials per carton, Rx only, Manufactured for: Cadence Pharmaceuticals, Inc., San Diego, CA 92130, NDC 43825-102-01, UPC 3 43825 10201 7.

by Cadence Pharmaceuticals

Reason
Presence of Particulate Matter: The firm initiated the recall due to visible presence of particulate matter.
Recall initiated
July 24, 2012
Reported by FDA
August 8, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5 mg/500 mg per 15 mL, 16 fl oz (473 mL) bottle, Rx only, Mallinckrodt Inc., Hazelwood, MO 63042 USA, NDC 0406-0375-16, UPC 3 0406-0375-16 1.

by Mallinckrodt Inc.

Reason
CGMP Deviations: This product is being recalled because expired flavoring was used in the manufacturing of these lots.
Recall initiated
May 25, 2012
Reported by FDA
August 8, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5 mg/500 mg per 15 mL, 16 fl oz (473 mL) bottle, Rx only, Mallinckrodt Inc., Hazelwood, MO 63042 USA, NDC 0406-0375-16, UPC 3 0406-0375-16 1.

by Mallinckrodt Inc.

Reason
Subpotent (Multiple Ingredient) Drug: Low out of specification assay results for the hydrocodone bitartrate ingredient was found.
Recall initiated
May 25, 2012
Reported by FDA
August 8, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Argatroban Injection 50 mg per 50ml (1 mg per ml) For Intravenous Infusion Only, a) Single Use Vial (NDC 42367-203-07), b) 10 Single Use Vials(NDC 42367-203-84), Rx Only, Manufactured by: Cipla LTD, India, Manufactured for: Eagle Pharmaceuticals, Inc. Woodcliff Lake, NJ 07677 USA, Marketed by: The Medicines Company, Parsippany, NJ 07054 USA

by Eagle Pharmaceuticals Inc.

Reason
A complaint was received from a hospital pharmacy on 11/10/11 for crystalline particulates in a single vial from Lot V10194. Additional small visible particles consisting of fibers were identified.
Recall initiated
December 2, 2011
Reported by FDA
August 8, 2012
Distribution
New Jersey

View recall →

Drug Recall Terminated Historical recordClass II

Metformin Hydrochloride Tablets, USP, 1000 mg, Rx only, 1000 count tablets per Bottle, Manufactured by: Cadila Healthcare LTD. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-030-10.

by Zydus Pharmaceuticals USA Inc

Reason
Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks. The same complainant also reported that metal shaving like material was observed on the surface of one tablet.
Recall initiated
March 14, 2012
Reported by FDA
August 8, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Tizanidine (Generic for: Zanaflex), 4 mg, 90 Tablets per Bottle, Rx only, , Mfg By: Dr Reddys Labs Ltd., Bachepally, IN 500 - 090, Packaged and distributed by STAT Rx USA, Gainesville, GA, NDC 16590-221-90.

by Stat Rx USA

Reason
Labeling: Label Mix-Up; Some bottles of Tizanidine 4mg Tablets, had the incorrect manufacturer (Actavis) printed on the label.
Recall initiated
July 23, 2012
Reported by FDA
August 1, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A division of Fougera Pharmaceuticals, Inc., Melville, New York 11747, NDC 0168-0215-60, UPC 3 0168-0215-60 0.

by Fougera Pharmaceuticals, Inc.

Reason
Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.
Recall initiated
June 7, 2012
Reported by FDA
August 1, 2012
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Dent's Extra Strength Toothache Gum, (benzocaine 20%), Net Wt. .035 Oz.. (1 g) box, C.S. Dent & Co., Erlanger, KY

by Grandpa Brands Co

Reason
Superpotent; benzocaine
Recall initiated
May 9, 2012
Reported by FDA
August 1, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Caplets, OTC, a) 16 ct. blister (NDC 0280-8005-16), b)24 ct. blister, Distributed by Bayer Health Care, Morristown, NJ 07962 (NDC 0280-8005-25)

by Bayer Healthcare, LLC

Reason
Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.
Recall initiated
April 26, 2012
Reported by FDA
July 25, 2012
Distribution
Product was distributed to 93 retail accounts/customers.

View recall →

Drug Recall Terminated Historical recordClass III

Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Gelcaps 24 ct. blister, OTC, Distributed by Bayer Health Care, Morristown, NJ 07962 NDC 0280-8015-24

by Bayer Healthcare, LLC

Reason
Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.
Recall initiated
April 26, 2012
Reported by FDA
July 25, 2012
Distribution
Product was distributed to 93 retail accounts/customers.

View recall →

Drug Recall Terminated Historical recordClass III

Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai - 400 030, Distributed by: PACK Pharmaceuticals, LLC, Buffalo Grove, IL 60089, NDC 16571-412-10.

by Pack Pharmaceuticals

Reason
Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.
Recall initiated
March 9, 2012
Reported by FDA
July 25, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Epinephrine Injection, USP, 1:1000 (1 mg/mL), 25 x 1 mL Ampules, For SC and IM Use, For IV and IC Use after Dilution, Rx Only, American Regent, Inc., Shirely, NY 11967 --NDC 0517-1071-25

by Luitpold Pharmaceuticals, Inc.

Reason
Presence of Particulate Matter
Recall initiated
April 24, 2012
Reported by FDA
July 25, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Pitocin (Oxytocin Injection, USP) Synthetic 10 units per mL 10 mL, Rx only, Manufactured and Distributed by: JHP Pharmaceuticals, LLC Rochester, MI 48307 NDC 42023-116-02

by JHP Pharmaceuticals, LLC

Reason
Labeling: Label Mix-up: Pitocin storage conditions should be labeled, "Store between 20¿ to 25¿C (68¿ to 77¿F)". Pitocin lot 225867 and part of Pitocin lot 231423 were labeled, "Store between 20¿ to 25¿C (28¿ to 77¿F)".
Recall initiated
June 5, 2012
Reported by FDA
July 25, 2012
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass I

Morphine Sulfate Injection, USP, 4mg/mL, 1 mL fill in 2.5 mL Carpuject Cartridge Unit with Luer Lock, packaged 10 Carpujects/carton, CII, Rx only, Hospira, Inc., Lake Forest, IL ---- NDC 0409-1258-30

by Hospira Inc.

Reason
Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL
Recall initiated
April 17, 2012
Reported by FDA
July 25, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prefera OB One Gel Capsules, 30 softgels, Rx Only, Manufactured by: IVC industries, Inc. Irving ton, NJ 07111, For: Alaven Pharmaceutical LLC Marietta, GA 30062, NDC 68220-086-30

by Meda Pharmaceuticals Inc.

Reason
Labeling: Presence of Undeclared Color Additive; The product is being recalled because several inactive ingredients were not included in the labeling for this product: Undeclared D&C Red #33, FD&C Blue #1, Titanium Dioxide Suspension, Purified Water USP.
Recall initiated
October 17, 2011
Reported by FDA
July 25, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

HYDROXYZINE HYDROCHLORIDE ORAL SOLUTION, USP, 10 mg/5 mL, 1 PINT (473 mL) bottle, Rx only, Mfg. for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-1310-58, UPC 3 0603-1310-58 4.

by Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals

Reason
Impurities/Degradation Products: High Out of Specification results for a known impurity resulted at the 12-month room temperature time point.
Recall initiated
July 6, 2012
Reported by FDA
July 25, 2012
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Hydrocodone Bitartrate & Acetaminophen Oral Solution 7.5 mg/325 mg per 15 mL, a) 15 mL Unit Dose Cups (50 unit dose cups per case), b) 473 mL Bottles, C III, Rx Only, Warning May be habit forming, Manufactured by VistaPharm, Largo, FL 33771, NDC a) 66689-023-50, b) NDC 66689-023-16.

by VistaPharm, Inc.

Reason
Impurities/Degradation Products: exceeded specification at 3 month stability testing
Recall initiated
May 30, 2012
Reported by FDA
July 18, 2012
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.